TODAY’S NEWSAbbott to acquire Visiogen for $400m…and, also named a top place to start your career.Meda - Astepro once-daily (for the treatment of the symptoms of seasonal and perennial allergic rhinitis) approved by FDA.Forest Labs on the hot...
Topics: Abbott, FDA, Forest Labs, meda, Pharma, Pharma News, Pharmaceutical, Top News

{"title":"Impactiviti Daily 090409","post_url":"http:\/\/impactiviti.wordpress.com\/2009\/09\/04\/impactiviti-daily-090409\/","feed_url":"http:\/\/impactiviti.wordpress.com\/feed\/","author":"StickyFigure","date":"2009-09-04 07:53:56","summary":"TODAY\u2019S NEWSAbbott to acquire Visiogen for $400m…and, also named a top place to start your career.Meda - Astepro once-daily (for the treatment of the symptoms of seasonal and perennial allergic rhinitis) approved by FDA.Forest Labs on the hot..."}

TODAY’S NEWSSepracor to be purchased by Japanese company, according to report – By purchasing Sepracor, which sells drugs to treat central nervous system and respiratory disorders, Dainippon would be able to open a sales channel in the U.S. for...
Topics: Forest Labs, Genentech, Marketing, Novartis, Oncology, Pfizer, Pharma, Pharma News, Pharmaceutical, Scandal, Training Needs

{"title":"Impactiviti Daily 090309","post_url":"http:\/\/impactiviti.wordpress.com\/2009\/09\/03\/impactiviti-daily-090309\/","feed_url":"http:\/\/impactiviti.wordpress.com\/feed\/","author":"StickyFigure","date":"2009-09-03 01:10:54","summary":"TODAY\u2019S NEWSSepracor to be purchased by Japanese company, according to report – By purchasing Sepracor, which sells drugs to treat central nervous system and respiratory disorders, Dainippon would be able to open a sales channel in the U.S. for..."}

TODAY’S NEWSCombo pills for high cholesterol: no better than higher doses of single drug? Interesting study results.Should we really be doing all those PSA tests for prostate cancer? Maybe not.Shire’s Gaucher drug on the fast track, due to...
Topics: Genzyme, Medicine, Pfizer, Pharma, Pharma News, Pharmaceutical, Social Media, Statins, Top News, Training Needs

{"title":"Impactiviti Daily 090109","post_url":"http:\/\/impactiviti.wordpress.com\/2009\/09\/01\/impactiviti-daily-090109\/","feed_url":"http:\/\/impactiviti.wordpress.com\/feed\/","author":"StickyFigure","date":"2009-09-01 06:39:48","summary":"TODAY\u2019S NEWSCombo pills for high cholesterol: no better than higher doses of single drug? Interesting study results.Should we really be doing all those PSA tests for prostate cancer? Maybe not.Shire’s Gaucher drug on the fast track, due to..."}

Did you know you can get Impactiviti Daily (Top Pharma News) direct to your Inbox each morning? Just click here to subscribe!TODAY’S NEWSP&G’s drug unit to be snapped up, by… – Warner Chilcott Ltd, a specialty drug maker, is...
Topics: FDA, Johnson and Johnson, Lundbeck, Pharma, Pharma News, Pharmaceutical, shire, Teva, Top News, Training, Warner Chilcott

{"title":"Impactiviti Daily 082409","post_url":"http:\/\/impactiviti.wordpress.com\/2009\/08\/24\/impactiviti-daily-082409\/","feed_url":"http:\/\/impactiviti.wordpress.com\/feed\/","author":"StickyFigure","date":"2009-08-24 05:59:13","summary":"Did you know you can get Impactiviti Daily (Top Pharma News) direct to your Inbox each morning? Just click here to subscribe!TODAY\u2019S NEWSP&G’s drug unit to be snapped up, by… – Warner Chilcott Ltd, a specialty drug maker, is..."}

TODAY’S NEWSWhy Pharma wants Obamacare. Thought provoking analysis from Forbes.I like the headline: No Non-sinister Deed goes Unpunished. An interesting story about lobbying, healthcare reform, and The Medicines Company.Takeda re-acquires Actos...
Topics: Novartis, Pharma, Pharma News, Pharmaceutical, Sales training, Social Media, Takeda, Top News, Video

{"title":"Impactiviti Daily 082109","post_url":"http:\/\/impactiviti.wordpress.com\/2009\/08\/21\/impactiviti-daily-082109\/","feed_url":"http:\/\/impactiviti.wordpress.com\/feed\/","author":"StickyFigure","date":"2009-08-21 05:38:13","summary":"TODAY\u2019S NEWSWhy Pharma wants Obamacare. Thought provoking analysis from Forbes.I like the headline: No Non-sinister Deed goes Unpunished. An interesting story about lobbying, healthcare reform, and The Medicines Company.Takeda re-acquires Actos..."}